Currently Enrolling Research Studies
"People with Diabetes Mellitus live each day in their own clinical study, as subject and investigator, generating the data that leads to their well-being" -James Field MD, Endocrinologist
For the past 25 years we have been fortunate to participate in original and sponsored Diabetes research, helping bring many of our current diabetes treatments to physicians and patients. Research keeps us at the apex of diabetes experience and understanding. And it offers free care and medicines to people with diabetes who participate in clinical studies. Currently there are many diabetes studies ongoing at our center and at diabetes centers across the world.
Currently Enrolling Studies at University Diabetes & Endocrine Research Center
We are pleased to offer clinical study opportunities for people with newly diagnosed COVID-19, OR type 2 diabetes, AND/OR Liver disease.
And A new insulin study for type 1 diabetes will begin as soon as the pandemic permits.
And A new insulin study for type 1 diabetes will begin as soon as the pandemic permits.
Type 2 Diabetes Studies:
|
COVID-1Treatment Study:
for Persons within 72 hours of COVID-19 symptoms and/or positive RNA test. Monoclonal Antibody Infusion Study Offers 1 hour infusion of spike protein antibodies to bind and dispose of COVID-19 virus. This study is placebo controlled. For all participants, Laboratory monitoring of COVID allows your doctor to prevent and treat any COVID complications. |
Liver Disease Studies:
Patients with Nonalcoholic Steatohepatitis If you have fatty liver with elevated liver function tests OR cirrhosis with portal hypertension you may qualify for studies which will define the stage and severity of liver problems and test medicines to improve liver function |
If you are interested in hearing more about these or other studies, please call us at 423-265-0462 or:
To find out more please fill out the contact form below.
To find out more please fill out the contact form below.